ATLANTA -- Patients who have had an episode of idiopathic deep vein thrombosis can be adequately protected against a recurrence with just 3 months of oral anticoagulation therapy, providing they do not have residual vein thrombosis. The finding was reported by Italian researchers at the annual ...